Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Med Food ; 17(3): 374-83, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24588719

RESUMEN

The metabolic syndrome is a major worldwide health care issue and a dominant risk factor for cardiovascular disease. The liver manifestations of this syndrome include nonalcoholic fatty liver disease (NAFLD) and its progressive variant nonalcoholic steatohepatitis (NASH). Although significant research has been performed, the basic pathogenesis of NAFLD/NASH remains controversial and effective treatments are still unavailable. We have previously reported on a murine model of NASH induced by the neonatal injection of monosodium glutamate (MSG), which includes the clinical manifestations of central obesity, diabetes, hyperlipidemia, and ultimately liver inflammation, fibrosis, and cancer. Although MSG is considered a safe food additive, its administration to pregnant rats increases the voracity and growth hormone levels in the offspring. To further understand the biology of this model, we have investigated the influence of the calorie intake on these clinical manifestations by feeding animals a restrictive diet. MSG-treated animals fed a restrictive diet continue to manifest obesity and early stage NASH but have improvements in serum lipid profiles. At 12 months of age, mice had manifestations of obesity, whether animals were fed a restricted or control diet, but animals fed a restrictive diet had a reduction in the progression of NASH. In conclusion, MSG appears to be a critical factor in the initiation of obesity, whereas calorie intake may modulate the progression of disease.


Asunto(s)
Obesidad/dietoterapia , Glutamato de Sodio/efectos adversos , Animales , Dieta Reductora , Progresión de la Enfermedad , Hígado Graso/dietoterapia , Hígado Graso/etiología , Hígado Graso/metabolismo , Hígado Graso/patología , Humanos , Masculino , Ratones Endogámicos ICR , Enfermedad del Hígado Graso no Alcohólico , Obesidad/complicaciones , Obesidad/metabolismo , Glutamato de Sodio/metabolismo
2.
Clin Calcium ; 15(4): 666-72, 2005 Apr.
Artículo en Japonés | MEDLINE | ID: mdl-15802782

RESUMEN

Calcium intake was reported to be associated with peak bone mass. Vitamin D insufficiency, which is less severe than deficiency, is prevalent in the elderly and known to cause osteoporosis. Protein malnutrition increases the fracture risk due to decreased bone mineral density and muscle weakness. Other nutrients have also been reported to be associated with osteoporosis. Thus nutritional aspect of osteoporosis should be interpreted from the broader perspectives. Since nutritional status greatly varies from one nation to another, we must add our original evidence in Japan to the report from WHO.


Asunto(s)
Fenómenos Fisiológicos de la Nutrición , Osteoporosis/etiología , Calcio/deficiencia , Calcio de la Dieta/administración & dosificación , Proteínas en la Dieta/administración & dosificación , Humanos , Japón , Estado Nutricional , Osteoporosis/dietoterapia , Osteoporosis/prevención & control , Deficiencia de Proteína/complicaciones , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/complicaciones , Vitamina K/administración & dosificación , Deficiencia de Vitamina K/complicaciones , Organización Mundial de la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA